August 24, 2023 03:38 PM EDTUpdated 03:48 PM
Pharma
FDA+

CMS’ Medicare ne­go­ti­a­tion list is com­ing next week. Here’s what to ex­pect

Nicole DeFeudis

Editor

Lia DeGroot

The clock is tick­ing as phar­ma com­pa­nies wait to see what 10 Medicare Part D drugs will be up for the first round of price …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Is there still hope for Sum­mit's can­cer drug buried in the da­ta?

MIT sci­en­tists’ AI mod­el one-ups Al­phaFold 3, takes on ‘fun­da­men­tal is­sue’ in drug R&D

EMA con­sid­ers se­ri­ous eye con­di­tion a ‘very rare’ side ef­fect of semaglu­tide 

Up­dat­ed: Oma­da Health rose 21% in its pub­lic mar­ket de­but

Biotech ranks as Chi­na’s best shot to sur­pass US in emerg­ing tech, re­port finds

sponsored

Cy­ti­va and Eu­rek­aBio form strate­gic part­ner­ship to ad­vance lentivi­ral vec­tor man­u­fac­tur­ing for cell and gene ther­a­py ...

A service from the Financial Times